Machine learning based on gadoxetic acid-enhanced MRI for differentiating atypical intrahepatic mass-forming cholangiocarcinoma from poorly differentiated hepatocellular carcinoma
ConclusionThe clinical-radiomics model is an effective tool to distinguish aIMCC from pHCC and may provide additional value for the development of treatment plans.Graphical abstract
Source: Abdominal Imaging - Category: Radiology Source Type: research
More News: Bile Duct Cancer | Cancer & Oncology | Carcinoma | Cholangiocarcinoma | Hepatocellular Carcinoma | Learning | Liver Cancer | Radiology | Study | Training | Universities & Medical Training